What To Know About Aducanumab and Slowing the Progression of Alzheimer Disease

Video

Pharmacy Times spoke to Dr. Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.

Pharmacy Times spoke to Dr.Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.

Related Videos
Image credit: goodluz | stock.adobe.com
Elderly woman hands putting missing white jigsaw puzzle piece down into the place as a human brain shape | Image credit: Orawan - stock.adobe.com
Related Content
Mosquito sucking blood -- Image credit: auimeesri | stock.adobe.com

Climate Change Increases Rate of Infectious Diseases, Expert Says

April 18th 2024
Article
What to Know About the Approval of Lecanemab-irmb

What to Know About the Approval of Lecanemab-irmb

August 4th 2023
Podcast
3d rendered medically accurate illustration of amyloid plaques on a alzheimer nerve cell | Image Credit: Sebastian Kaulitzki - stock.adobe.com

FDA Grants Breakthrough Device Designation to Assay Supporting Earlier Diagnosis of Alzheimer Disease

April 17th 2024
Article
Pharmacy Focus: Psychedelic Pharmacy - The Future of Ketamine

Pharmacy Focus: Psychedelic Pharmacy - The Future of Ketamine

August 26th 2022
Podcast
Pharmacist feeling overwhelmed -- Image credit: Krakenimages.com | stock.adobe.com

April Is Stress Awareness Month: A Little Humbling Self-Awareness May Go a Long Way

April 16th 2024
Article
Senior man suffering from knee pain indoors. Space for text | Image credit: New Africa | stock.adobe.com

Study: Blended Antioxidant Supplement Could Improve Age-Related Health Decline

April 8th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.